메뉴 건너뛰기
Diabetes Care
Volumn 30, Issue 7, 2007, Pages
What dose of folic acid should be used for pregnant diabetic women? [5]
Author keywords

[No Author keywords available]
Indexed keywords

FOLIC ACID; GLUCOSE;
EID: 34447117465     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0200     Document Type: Letter
Times cited : (13)
References (8)
  • 1
    • 0025017481 scopus 로고
    • Diabetes mellitus during pregnancy and the risk for specific birth defects: A population-based case-control study
    • Becerra JE, Khoury Mj, Cordero JF, Erickson JD: Diabetes mellitus during pregnancy and the risk for specific birth defects: a population-based case-control study. Pediatrics 85:1-9, 1990
    • (1990) Pediatrics , vol.85 , pp. 1-9
    • Becerra, J.E.1    Khoury, M.2    Cordero, J.F.3    Erickson, J.D.4
  • 2
    • 12744254882 scopus 로고    scopus 로고
    • Folic acid supplementation disminishes diabetes-and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro
    • Wentzel P, Gäreskog M, Eriksson UJ: Folic acid supplementation disminishes diabetes-and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 54:546-547, 2005
    • (2005) Diabetes , vol.54 , pp. 546-547
    • Wentzel, P.1    Gäreskog, M.2    Eriksson, U.J.3
  • 3
    • 0037626147 scopus 로고    scopus 로고
    • Do multivitamin supplements attenuate the risk for diabetes-associated birth deffects?
    • Correa A, Botto L, Liu Y, Mulinare J, Erikson JD: Do multivitamin supplements attenuate the risk for diabetes-associated birth deffects? Pediatrics 111:1146-1151, 2003
    • (2003) Pediatrics , vol.111 , pp. 1146-1151
    • Correa, A.1    Botto, L.2    Liu, Y.3    Mulinare, J.4    Erikson, J.D.5
  • 4
    • 0042734751 scopus 로고    scopus 로고
    • ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists: number 44, July 2003 (replaces committee opinion number 252, March 2001)
    • ACOG Committee on Practice Bulletins
    • ACOG Committee on Practice Bulletins: ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists: number 44, July 2003 (replaces committee opinion number 252, March 2001). Obstet Gynecol 102:203-213, 2003
    • (2003) Obstet Gynecol , vol.102 , pp. 203-213
  • 5
    • 1542652343 scopus 로고    scopus 로고
    • Genetics Committee and Executive and Council of the Society of Obstetricians and Gynaecologists of Canada: The use of folic acid for the prevention of neural tube defects and other congenital anomalies
    • Wilson RD, Davies G, Desilets V, Reid GJ, Summers A, Wyatt P, Young D, Genetics Committee and Executive and Council of the Society of Obstetricians and Gynaecologists of Canada: The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 25:959-973, 2003
    • (2003) J Obstet Gynaecol Can , vol.25 , pp. 959-973
    • Wilson, R.D.1    Davies, G.2    Desilets, V.3    Reid, G.J.4    Summers, A.5    Wyatt, P.6    Young, D.7
  • 6
    • 16544370325 scopus 로고    scopus 로고
    • Will mandatory folic acid fortification prevent or promote cancer?
    • Kim YI: Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80:1123-1138, 2004
    • (2004) Am J Clin Nutr , vol.80 , pp. 1123-1138
    • Kim, Y.I.1
  • 8
    • 30044452294 scopus 로고    scopus 로고
    • The pregnancies of women with type 2 diabetes: Poor outcomes but opportunities for improvement
    • Roland JM, Murphy HR, Ball V, Northcote-Wrightt J, Temple RC: The pregnancies of women with type 2 diabetes: poor outcomes but opportunities for improvement. Diabet Med 22:1774-1777, 2005
    • (2005) Diabet Med , vol.22 , pp. 1774-1777
    • Roland, J.M.1    Murphy, H.R.2    Ball, V.3    Northcote-Wrightt, J.4    Temple, R.C.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.